Born from the inspiration of Christy Bastian CRST-2 continues the mission of inhibiting PIM and enhancing the efficacy of anti-cancer drugs.

CRST-2 underscores our commitment to creating a future where cancer is not a life sentence but a treatable condition. We believe that by harnessing the power of synergy, we can tip the scales in favor of patients.


  • Licensing Status

    CRST-2 has research ongoing.

Project Details

Building on the successes and insights gained from CRST-1, CRST-2 continues work on the therapeutic combination of Linebacker and leading anti-cancer drugs to maximize their impact on cancer cells.